Top CDC leader to step down

The principal deputy director of the Centers for Disease Control and Prevention is stepping down from her role, marking the second high-profile departure from the agency in the span of a month.

Anne Schuchat, MD, the CDC’s No. 2 in command, will vacate her role this summer, after serving as a scientist with the CDC for more than 30 years. She has served as principal deputy director since 2015. The news was first reported by Politico and confirmed by the CDC.

“I have enormous gratitude for Dr. Schuchat’s leadership and contributions over three decades, and during this very challenging period for our country,” CDC Director Rochelle Walensky, MD, said in a statement. “I will remain forever grateful that our paths crossed, even for just a short while.”

Longtime senior scientist Nancy Messonnier announced her departure earlier in May. Messonnier led the CDC’s response to the COVID-19 pandemic, STAT News reported.

The departures come at a fraught time for the agency, which has faced criticism and praise for its handling of the COVID-19 pandemic across the Trump and Biden administrations. 

In recent months, Schuchat clashed with Walensky, a source told Politico. Prior to Walensky’s appointment by the Biden administration, Schuchat was once in the running for the top job as director. 

She was also involved in the CDC’s decision to temporarily pause the Johnson & Johnson COVID-19 vaccine in April. That decision was sharply criticized for causing confusion over vaccine safety and efficacy after the agency ultimately allowed the vaccine to continue to be distributed.

According to Politico, Schuchat also was involved in internal battles between CDC scientists and the Trump administration, after the Trump administration attempted to interfere with scientific reports, including one she authored.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries.